Early assessment of MCV to predict clinical outcome in patients with advanced gastrointestinal stromal tumors (GIST) receiving imatinib.
Anastasia Constantinidou
No relevant relationships to disclose
Dimitrios Krikelis
No relevant relationships to disclose
David Olmos
No relevant relationships to disclose
Michelle R. Scurr
No relevant relationships to disclose
Robin Lewis Jones
Honoraria - Novartis
Sue Ashley
No relevant relationships to disclose
Ian Robert Judson
Consultant or Advisory Role - Novartis (U)
Honoraria - Novartis
Research Funding - Novartis